Filing Details
- Accession Number:
- 0001179110-16-028576
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-11 16:35:51
- Reporting Period:
- 2016-08-09
- Filing Date:
- 2016-08-11
- Accepted Time:
- 2016-08-11 16:35:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1200493 | E Dorothy Puhy | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2016-08-09 | 1,621 | $0.00 | 33,811 | No | 4 | A | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2016-08-10 | 3,000 | $122.03 | 30,811 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2016-08-10 | 600 | $122.99 | 30,211 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2016-08-10 | 300 | $123.70 | 29,911 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | $12.69 | 2008-08-13 | 2017-08-08 | 0 | 8,000 | Direct |
| Common Stock | Stock Option (right to buy) | $18.63 | 2009-08-12 | 2018-08-13 | 0 | 13,500 | Direct |
| Common Stock | Stock Option (right to buy) | $7.67 | 2010-08-11 | 2019-08-12 | 0 | 13,500 | Direct |
| Common Stock | Stock Option (right to buy) | $9.99 | 2011-08-10 | 2020-08-11 | 0 | 13,500 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2017-08-08 | 0 | 8,000 | Direct |
| 2018-08-13 | 0 | 13,500 | Direct |
| 2019-08-12 | 0 | 13,500 | Direct |
| 2020-08-11 | 0 | 13,500 | Direct |
Footnotes
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- This option becomes exerciseable in full on the date set forth in Table II, Column 6.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $121.6600 and $122.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $122.8900 and $122.9867. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the later of: (a) August 9, 2017; or (b) the date of the Issuer's next annual meeting of stockholders.
Billionaire Hedge Funds
